carbimazole has been researched along with Encephalopathy, Hepatic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bañares-Cañizares, R; Castillo-Pradillo, M; Díaz-Fontenla, F; Díaz-Gómez, A; Fernández-García, P; Gancedo, P; García-Martínez, R; Guzmán-de-Villoria, JA; Ibañez-Samaniego, L | 1 |
| Banc, P; Coste, V; Epeirier, JM; Larrey, D; Michel, H; Pageaux, GP; Perrigault, PF | 1 |
2 other study(ies) available for carbimazole and Encephalopathy, Hepatic
| Article | Year |
|---|---|
Refractory hepatic encephalopathy in a patient with hypothyroidism: Another element in ammonia metabolism.
Topics: Adrenergic beta-Antagonists; Alcoholism; Ammonia; Antithyroid Agents; Brain; Carbimazole; Diagnosis, Differential; Disorders of Excessive Somnolence; Drug Resistance; Dysarthria; Electroencephalography; Embolization, Therapeutic; Female; Goiter, Nodular; Hepatic Encephalopathy; Humans; Hyperammonemia; Hypothyroidism; Liver Cirrhosis, Alcoholic; Magnetic Resonance Imaging; Middle Aged; Portal Vein; Portasystemic Shunt, Transjugular Intrahepatic; Propranolol; Renal Veins; Thyrotropin; Thyroxine; Tomography, X-Ray Computed; Vascular Malformations | 2017 |
Fulminant hepatitis after carbimazole and propranolol administration.
Topics: Adrenergic beta-Antagonists; Alanine Transaminase; Antithyroid Agents; Aspartate Aminotransferases; Carbimazole; Chemical and Drug Induced Liver Injury; Factor V; Female; Hepatic Encephalopathy; Humans; Jaundice; Liver Transplantation; Middle Aged; Propranolol; Prothrombin | 1996 |